FDA releases digital mammography rules

As recommendations have become a commonplace expectation on radiology reports, is there a point where we are crossing the line?

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

In a 10-year study involving over 5,400 women with nearly 85 percent having dense breasts, contrast-enhanced mammography (CEM) demonstrated a 95.9 percent sensitivity rate for breast cancer.

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

New research suggests that reviewing mammography images in order of ascending volumetric breast density as opposed to random reading of exams demonstrated reduced reading time and less fixation time on malignant lesions.

Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.